Enablex
Product Images NDC 54868-5363

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Enablex (NDC 54868-5363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Enablex (darifenacin) Structural Formula (Enablex 03)

Enablex (darifenacin) Structural Formula (Enablex 03)
FDA Label Image

Figure 1 Mean (sd) Steady State Darifenacin Plasma Concentration Time Profiles For Enablex® 7.5 And 15 mg In Healthy Volunteers Including Both Cyp2d6 Ems And Pms* (Enablex 04)

Figure 1 Mean (sd) Steady State Darifenacin Plasma Concentration Time Profiles For Enablex® 7.5 And 15 mg In Healthy Volunteers Including Both Cyp2d6 Ems And Pms* (Enablex 04)
FDA Label Image

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2a, Study 1 (Enablex 05)

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2a, Study 1 (Enablex 05)
FDA Label Image

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2b, Study 2 (Enablex 06)

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2b, Study 2 (Enablex 06)
FDA Label Image

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2c, Study 3 (Enablex 07)

Figures 2 A,b,c. Median Change From Baseline At Weeks 2, 6, 12 For Number Of Incontinence Episodes Per Week (studies 1, 2 And 3) Figure 2c, Study 3 (Enablex 07)
FDA Label Image

Principal Display Panel (7.5 mg)

Principal Display Panel (7.5 mg)
This is a label or tag for a product called "ENABLER 7.5K6" that was distributed by "PHYSICIANS TOTAL CARE". The label includes a lot number and expiration date, but not much else is provided. No other information is available from this text.*
FDA Label Image

Principal Display Panel (15 mg)

Principal Display Panel (15 mg)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.